Quest Diagnostics
849 hedge funds and large institutions have $13.6B invested in Quest Diagnostics in 2022 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 270 increasing their positions, 314 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
849
Holders Change
+1
Holders Change %
+0.12%
% of All Funds
14.36%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.12%
New
83
Increased
270
Reduced
314
Closed
70
Calls
$104M
Puts
$57.5M
Net Calls
+$46.1M
Net Calls Change
+$46.1M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$150M |
| 2 |
BlackRock
New York
|
$1.79B |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
$78.3M |
| 4 |
Morgan Stanley
New York
|
$254M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
$48.7M |
